EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PTEN Depletion Increases Radiosensitivity in Response to Ataxia Telangiectasia-Related-3 (ATR) Inhibition in Non-Small Cell Lung Cancer (NSCLC)

Victoria L Dunne, Mihaela Ghita-Pettigrew iD, Kelly M Redmond, Donna M Small, Sinéad Weldon iD, Clifford C Taggart, Kevin M Prise iD, Gerard G Hanna iD, Karl T Butterworth iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25147817 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Victoria L Dunne und 8 weiteren Autor:innen. Beteiligte Einrichtung: Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast BT9 7AE, UK. Hauptthemen laut MEDLINE: PTEN Phosphohydrolase, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Ataxia Telangiectasia Mutated Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Prostate Cancer UK, Queen’s Foundation, Queen’s University Belfast.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiotherapy (RT) treatment is an important strategy for the management of non-small cell lung cancer (NSCLC). Local recurrence amongst patients with late-stage NSCLC remains a challenge. The loss of PTEN has been associated with radio-resistance. This study aimed to examine the efficacy of RT combined with ataxia telangiectasia-mutated Rad3-related (ATR) inhibition using Ceralasertib in phosphatase and tensin homolog (PTEN)-depleted NSCLC cells and to assess early inflammatory responses indicative of radiation pneumonitis (RP) after combined-modality treatment. Small hairpin RNA (shRNA) transfections were used to generate H460 and A549 PTEN-depleted models. Ceralasertib was evaluated as a single agent and in combination with RT in vitro and in vivo. Histological staining was used to assess immune cell infiltration in pneumonitis-prone C3H/NeJ mice. Here, we report that the inhibition of ATR in combination with RT caused a significant reduction in PTEN-depleted NSCLC cells, with delayed DNA repair and reduced cell viability, as shown by an increase in cells in Sub G1. Combination treatment in vivo significantly inhibited H460 PTEN-depleted tumour growth in comparison to H460 non-targeting PTEN-expressing (NT) cell-line-derived xenografts (CDXs). Additionally, there was no significant increase in infiltrating macrophages or neutrophils except at 4 weeks, whereby combination treatment significantly increased macrophage levels relative to RT alone. Overall, our study demonstrates that ceralasertib and RT combined preferentially sensitises PTEN-depleted NSCLC models in vitro and in vivo, with no impact on early inflammatory response indicative of RP. These findings provide a rationale for evaluating ATR inhibition in combination with RT in NSCLC patients with PTEN mutations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PTEN PhosphohydrolaseCarcinoma, Non-Small-Cell LungLung NeoplasmsAtaxia Telangiectasia Mutated ProteinsRadiation TolerancePyrimidinesAnimalsHumansMiceCell Line, TumorPyrazinesXenograft Model Antitumor AssaysDNA RepairIndolesMorpholinesSulfonamides

Stichwörter der Autor:innen

ATR inhibitionDNA damagePTENnon-small cell lung cancerradiation pneumonitisradiotherapy

Substanzen

PTEN PhosphohydrolaseAtaxia Telangiectasia Mutated ProteinsPTEN protein, humanPyrimidinesceralasertibPyrazinesATR protein, humanIndolesMorpholinesSulfonamides

Autor:innen und Institutionen

  • Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast BT9 7AE, UK.
  • Airway Innate Immunity Research Group (AiiR), Wellcome Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast BT9 7AE, UK.
  • Northern Ireland Cancer Centre, Belfast Health and Social Care Trust, Belfast BT9 7AB, UK.

ORCID-Profile: Mihaela Ghita-Pettigrew, Sinéad Weldon, Kevin M Prise, Gerard G Hanna, Karl T Butterworth

Förderung

  • Cancer Research UK
  • Prostate Cancer UK
  • Queen’s Foundation, Queen’s University Belfast
  • LFT Charitable Trust
  • Prostate Cancer UK Career Acceleration Fellowship

Zitieren

APA

Dunne, V. L., Ghita-Pettigrew, M., Redmond, K. M., Small, D. M., Weldon, S., Taggart, C. C., Prise, K. M., Hanna, G. G., & Butterworth, K. T. (2024). PTEN Depletion Increases Radiosensitivity in Response to Ataxia Telangiectasia-Related-3 (ATR) Inhibition in Non-Small Cell Lung Cancer (NSCLC). International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25147817

Vancouver

Dunne VL, Ghita-Pettigrew M, Redmond KM, Small DM, Weldon S, Taggart CC, et al. PTEN Depletion Increases Radiosensitivity in Response to Ataxia Telangiectasia-Related-3 (ATR) Inhibition in Non-Small Cell Lung Cancer (NSCLC). International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25147817

BibTeX
@article{Dunne2024,
  author = {Dunne, Victoria L and Ghita-Pettigrew, Mihaela and Redmond, Kelly M and Small, Donna M and Weldon, Sinéad and Taggart, Clifford C and Prise, Kevin M and Hanna, Gerard G and Butterworth, Karl T},
  title = {PTEN Depletion Increases Radiosensitivity in Response to Ataxia Telangiectasia-Related-3 (ATR) Inhibition in Non-Small Cell Lung Cancer (NSCLC)},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25147817}
}
Kostenlos starten →